Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

Human metapneumovirus is similar to respiratory syncytial virus (RSV) and primarily affects children 5 years old and younger, Sobolewski said. However, adults, especially older adults, can also ...

Hospitals in China have been 'overwhelmed' by outbreak says WHO as NHS says people with respiratory symptoms should 'limit contact with others' ...

Cases of influenza continue to soar across Canada, meanwhile rates of respiratory syncytial virus, or RSV, and COVID-19 are ...

Human metapneumovirus (HMPV) is one of the lesser-known winter illnesses that can cause symptoms similar to a cold - here's everything you need to know about it ...

(Alliance News) - hVIVO PLC on Monday said it has signed a contract with Inhalon Biopharma Inc to test its antiviral candidate to treat respiratory syncytial virus. The London-based contract research ...

ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence immune enhancers to minimize the impact of viral respiratory infections, announces today it has received a ...